Table 2.
Prevalence of HPV, HR-HPV, LR-HPV, STIs, and HPV/STIs by different cervical cytology findings
| ||||
Cervical cytology findings | ||||
Variable | Normal (NILM) (n = 176) | ASC-US (n = 10) | LSIL (n = 4) | P-value |
HPV-positive | 117 (66.5) | 7 (70) | 4 (100) | 0.51 |
HR-HPV | 40 (22.7) | 0 (0) | 2 (50) | |
LR-HPV | 42 (23.9) | 3 (30) | 0 (0) | |
HR & LR HPV | 35 (19.9) | 4 (40) | 2 (50) | 0.08 |
STIs-positive | 14 (8) | 1 (10) | 0 (0) | 0.70 |
HPV/STIs | 13 (7.3) | 1 (10) | 0 | 0.67 |
Data presented as n (%). Chi-square test. HPV: Human papillomavirus, NILM: Negative for squamous intraepithelial lesion or malignancy, ASC-US: Atypical squamous cells of undetermined significance, LSIL: Low-grade squamous intraepithelial lesions, HR-HPV: High-risk HPV, LR-HPV: Low-risk HPV, HR/LR HPV: Co-infection of HR and LR HPV, STI: Sexually transmitted infections, HPV/STIs: Co-infection of HPV and STIs |